Address: Ataköy 7-8-9-10. Kısım Mah. Çobançeşme E-5 Yan Yol Cad. B Apt. No:20 2/165 Bakırköy - İstanbul
  • Call us
    +90 212 212 03 52
  • Working hours
    Mon - Sat 08:00 - 20:00
  • E-Mail
    info@tbyholding.com

We in the Press

Erdal Can Alkoclar

Erdal Can Alkoclar

Erdal Can Alkoclar currently works at the Biotechnological R&D, Mas Pharmaceutical Investment Corp.. Erdal Can Alkoclar is a Turkish inventor, scientist and investor. Alkoclar is the co-founder and running president of Yesilalkoclar R&D company. He is the sole inventor of 143 applied and 282 pending patents; 44 of them being in current PCT protection. Alkoclar also is the rights holder and applicant of the largest amount of pharmaceutical ingredient patents as sole individual in Turkey....

PRESS RELEASE-Patents of Tribor Arge, one of the Turkish chemical industry companies, will be opened to international investment

PRESS RELEASE-Patents of Tribor Arge, one of the Turkish chemical industry companies, will be opened to international investment

PRESS RELEASE-Patents of Tribor Arge, one of the Turkish chemical industry companies, will be opened to international investment With Erdal Can Alkoçlar, Chairman of the Board of Directors of Mas İlaç Yatırım With the agreement signed between Tribor Arge Board Chairman Nuri Murat Özayman, cooperation in all patents and know-how issues was realized. Alkoçlar said, "We are working with all our strength to invest today and tomorrow. Apart from drug production and...

BASIN BÜLTENİ-Türk kimya sanayi şirketlerinden Tribor Arge’nin patentleri, uluslarası yatırıma açılacak

BASIN BÜLTENİ-Türk kimya sanayi şirketlerinden Tribor Arge’nin patentleri, uluslarası yatırıma açılacak

Mas İlaç Yatırım Yönetim Kurulu Başkanı Erdal Can Alkoçlar ile Tribor Arge Yönetim Kurulu Başkanı Nuri Murat Özayman arasında  imzalanan anlaşma ile tüm patent ve know-how konularında işbirliği  gerçekleştirildi. Alkoçlar, "Bugünden yarına yatırım yapmak için var  gücümüzle çalışıyoruz. İlaç üretim ve patent paylaşımı dışında  sektörde yeni fikirleri ve çöz&uum...

TBY Holding